医院层面变量对髋部骨折结局的影响
本研究基于英国国家髋部骨折数据库(NHFD)2018基准摘要与设施调查的公开审计数据,回顾性分析176家医院、66,578例髋部骨折患者,评估医院层面服务特征对30天死亡率及护理过程指标的影响。研究发现,参与髋部骨折临床试验是唯一与调整后30天死亡率相关的医院层面变量(未参与中位数6.3% vs 参与5.7%,p=0.039),年手术量和专用手术清单等与护理过程指标相关。
要点
- 参与髋部骨折临床试验与调整后30天死亡率降低相关(中位数5.7% vs 6.3%,p=0.039)。
- 年髋部骨折手术量更高和专用手术清单更多与急性住院时间缩短相关。
- 最佳实践关税达成与年手术量、专用手术清单、专用病房及试验参与相关。
核心结论
- 髋部骨折结局改善可能与医院层面服务特征相关,如参与髋部骨折研究试验、更大的髋部骨折手术量和专用手术清单的使用。
- 需要进一步使用患者层面数据的研究来证实这些发现。
研究设计与样本
- 回顾性分析来自国家髋部骨折数据库(NHFD)2018基准摘要和设施调查的公开审计数据。
- 分析纳入176家医院,每年髋部骨折病例中位数为366例(四分位距280至457),汇总了66,578例患者的数据。
- 主要结局指标为调整后30天死亡率;使用基于随机森林的链式方程多重插补(MICE)算法处理缺失值;根据数据类型采用Tobit回归、Siegal非参数线性回归和Mann-Whitney U检验进行单变量分析,p值<0.05表示统计学显著。
主要发现
- 唯一与主要结局30天死亡率相关的医院层面变量是髋部骨折试验参与情况(未参与:中位数6.3%;参与:中位数5.7%;p=0.039)。
- 及时手术与存在专用髋部骨折会议显著相关;急性住院时间缩短与年髋部骨折病例数更高和专用髋部骨折手术清单更多均显著相关。
- 最佳实践关税达成与年髋部骨折病例数更高、专用髋部骨折手术清单更多、存在专用髋部骨折病房以及参与髋部骨折试验显著相关。
关键数值与推荐
- 30天死亡率:未参与试验医院中位数6.3%,参与试验医院中位数5.7%,p=0.039。
- 纳入医院数176家,每年髋部骨折病例中位数366例(IQR 280–457),汇总患者数66,578例。
临床怎么用
- 医院可考虑参与髋部骨折临床试验、增加年手术量、设立专用髋部骨折手术清单和病房,以改善护理过程指标和结局。
- 临床应关注及时手术和专用髋部骨折会议,以优化护理流程。
局限性
- 本研究为探索性分析,使用公开审计数据,需要进一步使用患者层面数据的研究来证实这些发现。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: The aim of this study was to determine the impact of hospital-level service characteristics on hip fracture outcomes and quality of care processes measures. METHODS: This was a retrospective analysis of publicly available audit data obtained from the National Hip Fracture Database (NHFD) 2018 benchmark summary and Facilities Survey. Data extraction was performed using a dedicated proforma to identify relevant hospital-level care process and outcome variables for inclusion. The primary outcome measure was adjusted 30-day mortality rate. A random forest-based multivariate imputation by chained equation (MICE) algorithm was used for missing value imputation. Univariable analysis for each hospital level factor was performed using a combination of Tobit regression, Siegal non-parametric linear regression, and Mann-Whitney U test analyses, dependent on the data type. In all analyses, a p-value < 0.05 denoted statistical significance. RESULTS: Analyses included 176 hospitals, with a median of 366 hip fracture cases per year (interquartile range (IQR) 280 to 457). Aggregated data from 66,578 patients were included. The only identified hospital-level variable associated with the primary outcome of 30-day mortality was hip fracture trial involvement (no trial involvement: median 6.3%; trial involvement: median 5.7%; p = 0.039). Significant key associations were also identified between prompt surgery and presence of dedicated hip fracture sessions; reduced acute length of stay and both a higher number of hip fracture cases per year and more dedicated hip fracture operating lists; Best Practice Tariff attainment and greater number of hip fracture cases per year, more dedicated hip fracture operating lists, presence of a dedicated hip fracture ward, and hip fracture trial involvement. CONCLUSION: Exploratory analyses have identified that improved outcomes in hip fracture may be associated with hospital-level service characteristics, such as hip fracture research trial involvement, larger hip fracture volumes, and the use of theatre lists dedicated to hip fracture surgery. Further research using patient level data is warranted to corroborate these findings. Cite this article: Bone Joint J 2021;103-B(10):1627-1632.
引用
- Farrow L, Hall AJ, Ablett AD, et al. The influence of hospital-level variables on hip fracture outcomes. Bone Joint J. 2021. PMID: 34587811. doi:10.1302/0301-620X.103B10.BJJ-2021-0461.R1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。